Key Drivers
- Strong cash conversion
- Extremely high debt
- Negative net income
AIAI Summary
Ingevity is best viewed now as a deleveraging, cash-generation turnaround rather than an organic-growth specialty-chemicals story — the investment case hinges on timely divestiture proceeds being applied to debt to materially cut net leverage and validate management's 2026 FCF targets. If debt reduction and APT/Performance Materials recovery occur as guided, the stock can re-rate on sustainable cash flow; if divestitures are delayed, FCF misses occur, or auto/commodity pressures persist, downside risk is acute given the thin equity base and refinancing sensitivity.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong cash conversion
- •Extremely high debt
- •Negative net income
NGVT generates strong operating cash flow and gross margins but is undermined by extreme leverage, recurring net losses and stretched valuation.
Price Behavior
Key Price Behavior Insights:
- •Short-term downtrend
- •Support testing
- •Elevated volatility
Over the last month NGVT dropped about 12% from $72.19 to $63.62, sits below its last-month average (~$67.80) indicating short-term downtrend, testing $63–$64 support with resistance at $71–$72 and heightened volatility raising downside risk.
~9‑point swing from
Sentiment & News
Key News Insights:
- •Q4 loss
- •Board turnover
- •Institutional buying
Ingevity swung to a Q4 loss and missed EPS as revenues fell on weak auto and polymer demand, while founding directors plan to depart and institutional investors added to positions.
Near‑term pressure from soft end‑markets and a negative earnings surprise may weigh on the stock, though continued institutional buying and governance changes could support medium‑term confidence
Similar Companies in Basic Materials
Other companies in the same sector with AI ratings